Study of INV-202 in Patients With Obesity and Metabolic Syndrome
Conditions:   Obesity;   Metabolic Syndrome Intervention:   Drug: INV-202 Sponsor:   Inversago Pharma Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2023 Category: Research Source Type: clinical trials

Study of INV-202 in Patients With Obesity and Metabolic Syndrome
Conditions:   Obesity;   Metabolic Syndrome Interventions:   Drug: INV-202;   Drug: Placebo Sponsor:   Inversago Pharma Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2023 Category: Research Source Type: clinical trials

Study of INV-202 in Patients With Obesity and Metabolic Syndrome
Conditions:   Obesity;   Metabolic Syndrome Intervention:   Drug: INV-202 Sponsor:   Inversago Pharma Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2023 Category: Research Source Type: clinical trials